2m 2m 2m 2m 2m 2m 2m
DYNE THERAPEUTCS (DYN)
NASDAQ
$20.60-$0.27 (-1.31%)
Price as of Jun 23, 2026 9:31 AM EDT- $3.5BMarket Cap
- 105.41%1-Year Change
- BiotechnologyIndustry
DYNE THERAPEUTCS (DYN)
$20.60-$0.27 (-1.31%)
DYN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $20.87 | ||
Change | +$1.07 (+5.40%) | ||
Open | $20.18 | ||
High | $20.98 | ||
Low | $20.11 | ||
Previous Close | $19.80 | ||
Volume | 2,560,455 | ||
30-Day Average Volume | 1,871,703 | ||
1-Week Change | 11.43% | ||
1-Month Change | 20.15% | ||
1-Year Change | 105.41% | ||
3-Year Change | 77.62% | ||
5-Year Change | 0.05% | ||
Fundamentals | |||
Shares Outstanding | 165.3M | ||
Total Assets | $1.1B | ||
Market Cap | $3.5B | ||
Enterprise Value | $2.9B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$120.9M | ||
Free Cash Flow | -$145.1M | ||
EBIT | -$116.7M | ||
EBITDA | -$116.1M | ||
Net Working Capital | $969.8M | ||
EPS | -$0.73 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -29 | ||
PEG | -8 | ||
Price/Free Cash Flow | -24 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue